Global Non-opioid Analgesics Market Growth 2025-2031

April 2025 | 87 pages | ID: G4F589C0DF16EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.

The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.

Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.

In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.

LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.

This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Analog Vacuum Regulator
• Digital Vacuum Regulator

Segmentation by Application:

• Clinically
• Surgical

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Ohio Medical
• Amico
• Precision Medical
• Air Liquid Healthcare
• Integral
• Allied Healthcare Products
• Shanghai Amcaremed Technology
• Acare
• Hersill

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Vacuum Regulator market?

What factors are driving Medical Vacuum Regulator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Vacuum Regulator market opportunities vary by end market size?

How does Medical Vacuum Regulator break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Non-opioid Analgesics Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Non-opioid Analgesics by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Non-opioid Analgesics by Country/Region, 2020, 2024 & 2031
2.2 Non-opioid Analgesics Segment by Type
  2.2.1 NSAIDs
  2.2.2 Acetaminophen
  2.2.3 Local Anesthetics
2.3 Non-opioid Analgesics Sales by Type
  2.3.1 Global Non-opioid Analgesics Sales Market Share by Type (2020-2025)
  2.3.2 Global Non-opioid Analgesics Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Non-opioid Analgesics Sale Price by Type (2020-2025)
2.4 Non-opioid Analgesics Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Non-opioid Analgesics Sales by Application
  2.5.1 Global Non-opioid Analgesics Sale Market Share by Application (2020-2025)
  2.5.2 Global Non-opioid Analgesics Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Non-opioid Analgesics Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Non-opioid Analgesics Breakdown Data by Company
  3.1.1 Global Non-opioid Analgesics Annual Sales by Company (2020-2025)
  3.1.2 Global Non-opioid Analgesics Sales Market Share by Company (2020-2025)
3.2 Global Non-opioid Analgesics Annual Revenue by Company (2020-2025)
  3.2.1 Global Non-opioid Analgesics Revenue by Company (2020-2025)
  3.2.2 Global Non-opioid Analgesics Revenue Market Share by Company (2020-2025)
3.3 Global Non-opioid Analgesics Sale Price by Company
3.4 Key Manufacturers Non-opioid Analgesics Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Non-opioid Analgesics Product Location Distribution
  3.4.2 Players Non-opioid Analgesics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NON-OPIOID ANALGESICS BY GEOGRAPHIC REGION

4.1 World Historic Non-opioid Analgesics Market Size by Geographic Region (2020-2025)
  4.1.1 Global Non-opioid Analgesics Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Non-opioid Analgesics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non-opioid Analgesics Market Size by Country/Region (2020-2025)
  4.2.1 Global Non-opioid Analgesics Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Non-opioid Analgesics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non-opioid Analgesics Sales Growth
4.4 APAC Non-opioid Analgesics Sales Growth
4.5 Europe Non-opioid Analgesics Sales Growth
4.6 Middle East & Africa Non-opioid Analgesics Sales Growth

5 AMERICAS

5.1 Americas Non-opioid Analgesics Sales by Country
  5.1.1 Americas Non-opioid Analgesics Sales by Country (2020-2025)
  5.1.2 Americas Non-opioid Analgesics Revenue by Country (2020-2025)
5.2 Americas Non-opioid Analgesics Sales by Type (2020-2025)
5.3 Americas Non-opioid Analgesics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Non-opioid Analgesics Sales by Region
  6.1.1 APAC Non-opioid Analgesics Sales by Region (2020-2025)
  6.1.2 APAC Non-opioid Analgesics Revenue by Region (2020-2025)
6.2 APAC Non-opioid Analgesics Sales by Type (2020-2025)
6.3 APAC Non-opioid Analgesics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Non-opioid Analgesics by Country
  7.1.1 Europe Non-opioid Analgesics Sales by Country (2020-2025)
  7.1.2 Europe Non-opioid Analgesics Revenue by Country (2020-2025)
7.2 Europe Non-opioid Analgesics Sales by Type (2020-2025)
7.3 Europe Non-opioid Analgesics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Non-opioid Analgesics by Country
  8.1.1 Middle East & Africa Non-opioid Analgesics Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Non-opioid Analgesics Revenue by Country (2020-2025)
8.2 Middle East & Africa Non-opioid Analgesics Sales by Type (2020-2025)
8.3 Middle East & Africa Non-opioid Analgesics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Analgesics
10.3 Manufacturing Process Analysis of Non-opioid Analgesics
10.4 Industry Chain Structure of Non-opioid Analgesics

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Non-opioid Analgesics Distributors
11.3 Non-opioid Analgesics Customer

12 WORLD FORECAST REVIEW FOR NON-OPIOID ANALGESICS BY GEOGRAPHIC REGION

12.1 Global Non-opioid Analgesics Market Size Forecast by Region
  12.1.1 Global Non-opioid Analgesics Forecast by Region (2026-2031)
  12.1.2 Global Non-opioid Analgesics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non-opioid Analgesics Forecast by Type (2026-2031)
12.7 Global Non-opioid Analgesics Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AbbVie Inc
  13.1.1 AbbVie Inc Company Information
  13.1.2 AbbVie Inc Non-opioid Analgesics Product Portfolios and Specifications
  13.1.3 AbbVie Inc Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AbbVie Inc Main Business Overview
  13.1.5 AbbVie Inc Latest Developments
13.2 Pfizer, Inc
  13.2.1 Pfizer, Inc Company Information
  13.2.2 Pfizer, Inc Non-opioid Analgesics Product Portfolios and Specifications
  13.2.3 Pfizer, Inc Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Pfizer, Inc Main Business Overview
  13.2.5 Pfizer, Inc Latest Developments
13.3 Teva Pharmaceutical Industries Ltd.
  13.3.1 Teva Pharmaceutical Industries Ltd. Company Information
  13.3.2 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Portfolios and Specifications
  13.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
  13.3.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.4 Viatris Inc.
  13.4.1 Viatris Inc. Company Information
  13.4.2 Viatris Inc. Non-opioid Analgesics Product Portfolios and Specifications
  13.4.3 Viatris Inc. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Viatris Inc. Main Business Overview
  13.4.5 Viatris Inc. Latest Developments
13.5 Centrexion Therapeutics
  13.5.1 Centrexion Therapeutics Company Information
  13.5.2 Centrexion Therapeutics Non-opioid Analgesics Product Portfolios and Specifications
  13.5.3 Centrexion Therapeutics Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Centrexion Therapeutics Main Business Overview
  13.5.5 Centrexion Therapeutics Latest Developments
13.6 Cara Therapeutics
  13.6.1 Cara Therapeutics Company Information
  13.6.2 Cara Therapeutics Non-opioid Analgesics Product Portfolios and Specifications
  13.6.3 Cara Therapeutics Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Cara Therapeutics Main Business Overview
  13.6.5 Cara Therapeutics Latest Developments
13.7 Medropharm GmbH.
  13.7.1 Medropharm GmbH. Company Information
  13.7.2 Medropharm GmbH. Non-opioid Analgesics Product Portfolios and Specifications
  13.7.3 Medropharm GmbH. Non-opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Medropharm GmbH. Main Business Overview
  13.7.5 Medropharm GmbH. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Non-opioid Analgesics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non-opioid Analgesics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of NSAIDs
Table 4. Major Players of Acetaminophen
Table 5. Major Players of Local Anesthetics
Table 6. Global Non-opioid Analgesics Sales by Type (2020-2025) & (K Units)
Table 7. Global Non-opioid Analgesics Sales Market Share by Type (2020-2025)
Table 8. Global Non-opioid Analgesics Revenue by Type (2020-2025) & ($ million)
Table 9. Global Non-opioid Analgesics Revenue Market Share by Type (2020-2025)
Table 10. Global Non-opioid Analgesics Sale Price by Type (2020-2025) & (US$/Unit)
Table 11. Global Non-opioid Analgesics Sale by Application (2020-2025) & (K Units)
Table 12. Global Non-opioid Analgesics Sale Market Share by Application (2020-2025)
Table 13. Global Non-opioid Analgesics Revenue by Application (2020-2025) & ($ million)
Table 14. Global Non-opioid Analgesics Revenue Market Share by Application (2020-2025)
Table 15. Global Non-opioid Analgesics Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Non-opioid Analgesics Sales by Company (2020-2025) & (K Units)
Table 17. Global Non-opioid Analgesics Sales Market Share by Company (2020-2025)
Table 18. Global Non-opioid Analgesics Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Non-opioid Analgesics Revenue Market Share by Company (2020-2025)
Table 20. Global Non-opioid Analgesics Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Non-opioid Analgesics Producing Area Distribution and Sales Area
Table 22. Players Non-opioid Analgesics Products Offered
Table 23. Non-opioid Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-opioid Analgesics Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Non-opioid Analgesics Sales Market Share Geographic Region (2020-2025)
Table 28. Global Non-opioid Analgesics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Non-opioid Analgesics Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Non-opioid Analgesics Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Non-opioid Analgesics Sales Market Share by Country/Region (2020-2025)
Table 32. Global Non-opioid Analgesics Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Non-opioid Analgesics Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Non-opioid Analgesics Sales by Country (2020-2025) & (K Units)
Table 35. Americas Non-opioid Analgesics Sales Market Share by Country (2020-2025)
Table 36. Americas Non-opioid Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Non-opioid Analgesics Sales by Type (2020-2025) & (K Units)
Table 38. Americas Non-opioid Analgesics Sales by Application (2020-2025) & (K Units)
Table 39. APAC Non-opioid Analgesics Sales by Region (2020-2025) & (K Units)
Table 40. APAC Non-opioid Analgesics Sales Market Share by Region (2020-2025)
Table 41. APAC Non-opioid Analgesics Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Non-opioid Analgesics Sales by Type (2020-2025) & (K Units)
Table 43. APAC Non-opioid Analgesics Sales by Application (2020-2025) & (K Units)
Table 44. Europe Non-opioid Analgesics Sales by Country (2020-2025) & (K Units)
Table 45. Europe Non-opioid Analgesics Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Non-opioid Analgesics Sales by Type (2020-2025) & (K Units)
Table 47. Europe Non-opioid Analgesics Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Non-opioid Analgesics Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Non-opioid Analgesics Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Non-opioid Analgesics Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Non-opioid Analgesics Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Non-opioid Analgesics
Table 53. Key Market Challenges & Risks of Non-opioid Analgesics
Table 54. Key Industry Trends of Non-opioid Analgesics
Table 55. Non-opioid Analgesics Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-opioid Analgesics Distributors List
Table 58. Non-opioid Analgesics Customer List
Table 59. Global Non-opioid Analgesics Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Non-opioid Analgesics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Non-opioid Analgesics Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Non-opioid Analgesics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Non-opioid Analgesics Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Non-opioid Analgesics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Non-opioid Analgesics Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Non-opioid Analgesics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Non-opioid Analgesics Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Non-opioid Analgesics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Non-opioid Analgesics Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Non-opioid Analgesics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Non-opioid Analgesics Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Non-opioid Analgesics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. AbbVie Inc Basic Information, Non-opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 74. AbbVie Inc Non-opioid Analgesics Product Portfolios and Specifications
Table 75. AbbVie Inc Non-opioid Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. AbbVie Inc Main Business
Table 77. AbbVie Inc Latest Developments
Table 78. Pfizer, Inc Basic Information, Non-opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer, Inc Non-opioid Analgesics Product Portfolios and Specifications
Table 80. Pfizer, Inc Non-opioid Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Pfizer, Inc Main Business
Table 82. Pfizer, Inc Latest Developments
Table 83. Teva Pharmaceutical Industries Ltd. Basic Information, Non-opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Portfolios and Specifications
Table 85. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Teva Pharmaceutical Industries Ltd. Main Business
Table 87. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 88. Viatris Inc. Basic Information, Non-opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 89. Viatris Inc. Non-opioid Analgesics Product Portfolios and Specifications
Table 90. Viatris Inc. Non-opioid Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Viatris Inc. Main Business
Table 92. Viatris Inc. Latest Developments
Table 93. Centrexion Therapeutics Basic Information, Non-opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 94. Centrexion Therapeutics Non-opioid Analgesics Product Portfolios and Specifications
Table 95. Centrexion Therapeutics Non-opioid Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Centrexion Therapeutics Main Business
Table 97. Centrexion Therapeutics Latest Developments
Table 98. Cara Therapeutics Basic Information, Non-opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 99. Cara Therapeutics Non-opioid Analgesics Product Portfolios and Specifications
Table 100. Cara Therapeutics Non-opioid Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Cara Therapeutics Main Business
Table 102. Cara Therapeutics Latest Developments
Table 103. Medropharm GmbH. Basic Information, Non-opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 104. Medropharm GmbH. Non-opioid Analgesics Product Portfolios and Specifications
Table 105. Medropharm GmbH. Non-opioid Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Medropharm GmbH. Main Business
Table 107. Medropharm GmbH. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Non-opioid Analgesics
Figure 2. Non-opioid Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Analgesics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Non-opioid Analgesics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non-opioid Analgesics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non-opioid Analgesics Sales Market Share by Country/Region (2024)
Figure 10. Non-opioid Analgesics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of NSAIDs
Figure 12. Product Picture of Acetaminophen
Figure 13. Product Picture of Local Anesthetics
Figure 14. Global Non-opioid Analgesics Sales Market Share by Type in 2025
Figure 15. Global Non-opioid Analgesics Revenue Market Share by Type (2020-2025)
Figure 16. Non-opioid Analgesics Consumed in Hospital Pharmacies
Figure 17. Global Non-opioid Analgesics Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Non-opioid Analgesics Consumed in Retail Pharmacies
Figure 19. Global Non-opioid Analgesics Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 20. Non-opioid Analgesics Consumed in Online Pharmacies
Figure 21. Global Non-opioid Analgesics Market: Online Pharmacies (2020-2025) & (K Units)
Figure 22. Global Non-opioid Analgesics Sale Market Share by Application (2024)
Figure 23. Global Non-opioid Analgesics Revenue Market Share by Application in 2025
Figure 24. Non-opioid Analgesics Sales by Company in 2025 (K Units)
Figure 25. Global Non-opioid Analgesics Sales Market Share by Company in 2025
Figure 26. Non-opioid Analgesics Revenue by Company in 2025 ($ millions)
Figure 27. Global Non-opioid Analgesics Revenue Market Share by Company in 2025
Figure 28. Global Non-opioid Analgesics Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Non-opioid Analgesics Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Non-opioid Analgesics Sales 2020-2025 (K Units)
Figure 31. Americas Non-opioid Analgesics Revenue 2020-2025 ($ millions)
Figure 32. APAC Non-opioid Analgesics Sales 2020-2025 (K Units)
Figure 33. APAC Non-opioid Analgesics Revenue 2020-2025 ($ millions)
Figure 34. Europe Non-opioid Analgesics Sales 2020-2025 (K Units)
Figure 35. Europe Non-opioid Analgesics Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Non-opioid Analgesics Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Non-opioid Analgesics Revenue 2020-2025 ($ millions)
Figure 38. Americas Non-opioid Analgesics Sales Market Share by Country in 2025
Figure 39. Americas Non-opioid Analgesics Revenue Market Share by Country (2020-2025)
Figure 40. Americas Non-opioid Analgesics Sales Market Share by Type (2020-2025)
Figure 41. Americas Non-opioid Analgesics Sales Market Share by Application (2020-2025)
Figure 42. United States Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Non-opioid Analgesics Sales Market Share by Region in 2025
Figure 47. APAC Non-opioid Analgesics Revenue Market Share by Region (2020-2025)
Figure 48. APAC Non-opioid Analgesics Sales Market Share by Type (2020-2025)
Figure 49. APAC Non-opioid Analgesics Sales Market Share by Application (2020-2025)
Figure 50. China Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 54. India Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Non-opioid Analgesics Sales Market Share by Country in 2025
Figure 58. Europe Non-opioid Analgesics Revenue Market Share by Country (2020-2025)
Figure 59. Europe Non-opioid Analgesics Sales Market Share by Type (2020-2025)
Figure 60. Europe Non-opioid Analgesics Sales Market Share by Application (2020-2025)
Figure 61. Germany Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 62. France Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Non-opioid Analgesics Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Non-opioid Analgesics Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Non-opioid Analgesics Sales Market Share by Application (2020-2025)
Figure 69. Egypt Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Non-opioid Analgesics Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-opioid Analgesics in 2025
Figure 75. Manufacturing Process Analysis of Non-opioid Analgesics
Figure 76. Industry Chain Structure of Non-opioid Analgesics
Figure 77. Channels of Distribution
Figure 78. Global Non-opioid Analgesics Sales Market Forecast by Region (2026-2031)
Figure 79. Global Non-opioid Analgesics Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Non-opioid Analgesics Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Non-opioid Analgesics Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Non-opioid Analgesics Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Non-opioid Analgesics Revenue Market Share Forecast by Application (2026-2031)